Silo Pharma, Inc. (SILO)
NASDAQ: SILO · IEX Real-Time Price · USD
1.710
-0.040 (-2.29%)
May 8, 2024, 9:52 AM EDT - Market open
Silo Pharma Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Silo Pharma stock has a target of 10, which predicts an increase of 484.80% from the current stock price of 1.71.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 28, 2023.
Analyst Ratings
According to 1 stock analyst, the rating for Silo Pharma is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Apr '24 | May '24 |
---|---|---|
Strong Buy | 1 | 1 |
Buy | 0 | 0 |
Hold | 0 | 0 |
Sell | 0 | 0 |
Strong Sell | 0 | 0 |
Total | 1 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Laidlaw & Co. | Laidlaw & Co. | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +484.80% | Aug 28, 2023 |
Financial Forecast
Revenue This Year
73.44K
from 72.10K
Increased by 1.86%
Revenue Next Year
73.44K
from 73.44K
EPS This Year
-0.57
from -1.20
EPS Next Year
-0.71
from -0.57
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 75,600 | 75,600 | 75,600 | 75,600 | 75,600 |
Avg | 73,440 | 73,440 | 73,440 | 73,440 | 73,440 |
Low | 70,560 | 70,560 | 70,560 | 70,560 | 70,560 |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 4.9% | 2.9% | 2.9% | 2.9% | 2.9% |
Avg | 1.9% | - | - | - | - |
Low | -2.1% | -3.9% | -3.9% | -3.9% | -3.9% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -0.59 | -0.74 | -0.76 | -1.18 | -1.27 |
Avg | -0.57 | -0.71 | -0.73 | -1.14 | -1.23 |
Low | -0.55 | -0.69 | -0.71 | -1.10 | -1.19 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.